Wuxi, China

Mengli Li

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jiangnan University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mengli Li. Retrieved from https://idiyas.com/inventor/mengli-li-s18zwprj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mengli Li and Advances in D-Allulose 3-Epimerase Production.

Introduction

Mengli Li is an inventor associated with Jiangnan University in Wuxi, China. Her work includes a patent on improving the production of D-allulose 3-epimerase, an enzyme relevant to bioengineering.

Latest Patents

Li is associated with 1 patent, titled “Strain Producing D-Allulose 3-Epimerase and Application Thereof.” The patent describes methods for improving enzyme expression by screening promoters and optimizing ribosome-binding sites. Recombinant constructs using the pP43NMK-hag and pP43NMK-hag-RBS4 vectors achieved shake-flask enzyme activities 1.30 and 1.69 times that of the original vector, respectively.

The disclosure also presents a non-antibiotic-resistance vector and recombinant strain. The strain 1A751-dal-/pP43NMK-hag-RBS4-dpe-dal reached a reported maximum fermentation enzyme activity of 24.72 U/mL in a shake flask and 714.8 U/mL in a fermenter.

Career Highlights

The patent highlights Li’s contribution to bioengineering research focused on enhancing enzyme expression and fermentation performance. Its reported results demonstrate improvements from laboratory shake-flask testing to fermenter-scale production.

Collaborations

The supplied information names Mengying Hu and Bo Jiang as Li’s coworkers. The patent’s described research is associated with Jiangnan University.

Conclusion

Mengli Li’s patent documents an approach to improving D-allulose 3-epimerase production through promoter screening, RBS optimization, and a non-antibiotic-resistance recombinant strain.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…